Medical News Today: Eczema elimination diet and foods to eat

Eczema is linked to inflammation in the body, so eating an anti-inflammatory diet may help reduce symptoms. Learn about which foods to eliminate.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Related Links:

Publication date: Available online 18 September 2018Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Gokhan Zengin, Azzurra Stefanucci, Maria João Rodrigues, Adriano Mollica, Luisa Custodio, Muhammad Zakariyyah Aumeeruddy, Mohamad Fawzi MahomoodallyAbstractThe genus Scrophularia has received much interest with regards to its traditional usages such as eczema, psoriasis, and mastitis. Yet, the medicinal properties of some species still need to be scientifically validated. The present study was designed to investigate into the biological properties of various solvent extracts (ethyl acetate, methano...
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
CONCLUSIONS: Colloidal oatmeal has been shown to safely reduce itching and irritation associated with AD and the severity of dry skin. These benefits, mediated by colloidal oatmeal's natural components, help to restore and maintain skin barrier function. This compound is safe, well tolerated, and can be effective as adjuvant treatment in AD . Moisturizers can reduce the dependency on topical corticosteroids and their potential adverse effects. PMID: 30207438 [PubMed - as supplied by publisher]
Source: Giornale Italiano di Dermatologia e Venereologia - Category: Dermatology Tags: G Ital Dermatol Venereol Source Type: research
We describe a 68-year-old female who presented to the dermatology office with a previous history of over 30 BCCs that had been previously biopsied and/or surgically removed. However, the patient had been lost to follow up for several years and had not been seen by a skin specialist. In the interim, she had been misdiagnosed as having eczematous or psoriatic lesions by primary care providers. Patients with Gorlin syndrome are even harder to diagnose as their skin cancers often do not possess the classic features associated with a basal cell or squamous cell carcinoma. When in doubt, and especially if failing topical therapy...
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research
Cutaneous T-cell lymphoma (CTCL) patients typically present with skin lesions, that seem inflammatory and in the initial disease stages are commonly mistaken for an inflammatory skin disease such as eczema or psoriasis. For inflammatory conditions like psoriasis it has been shown, that the expression of antimicrobial peptides (AMP) in lesional skin differs from healthy skin. With the present study we wanted to characterize the expression of AMPs in the skin of patients with CTCL.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Conditions:   Keloid;   Alopecia Areata;   Acne;   Hypertrophic Scar;   Epidermal Inclusion Cyst;   Frontal Fibrosing Alopecia;   Lichen Plano-Pilaris;   Keratoacanthoma;   Plaque Psoriasis;   Lichen Simplex Chronicus;   Prurigo Nodularis;   Nummular Eczema;   Granuloma Annulare;   M orphea;   Lichen Planus Interventions:   Drug: Corticosteroid with lidocaine;   Drug: Corticosteroid with normal saline Sponsor:   Vanderbilt Uni...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Strata Skin Sciences (NSDQ:SSKN) said yesterday it won FDA 510(k) clearance for the Multi-Micro Dose tip designed for use with its Xtrac 308nm excimer laser. The newly cleared tip is indicated for use in conjunction with the Horsham, Penn.-based company’s Xtrac laser system to filter narrow band UVB light at delivery, intended to individualize non-blistering doses during procedures. The MMD tip is designed to apply multiple level doses of energy to the patient’s psoriatic plaque to identify maximum sub-blistering energy dose for treatment zones so that physicians can design an optimal dose for each patient...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Cosmetic/Aesthetic Food & Drug Administration (FDA) Regulatory/Compliance Strata Skin Sciences Source Type: news
The nail is a mirror of our health. Nail dystrophy is very common and associated with various diseases. The causes of nail dystrophies are related to infections (fungus, bacteria, and virus), congenital disorders, environmental inputs (such as trauma and drugs), various cutaneous diseases (psoriasis, lichen planus, eczema, etc), and systemic conditions. A 4-year-old boy visited our clinic with nail dystrophy which started 4 months ago. Nail changes were observed including onycholysis with oil-drop discoloration, superficial fragility and onychomadesis of the proximal nail plate, koilonychia, and onychorrhexis.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
We describe 3 pediatric patients who developed paradoxic eczema following cardiac transplantation in infancy while on systemic antirejection therapy including tacrolimus, a drug widely used topically to treat eczema.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
Introduction: Emollient therapy is the mainstay for treating dry skin conditions such as atopic eczema and psoriasis. Because there is generally a lack of comparative data on emollient effectiveness, health care professionals choose between them based instead primarily on patient preference and cost. The National Institute for Health and Care Excellence (NICE, based in the U.K.) has therefore urged more research to be conducted in this area. For this purpose, ex vivo human skin offers an efficient and reliable means of comparing the hydration effects of multiple preparations.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
Introduction: The impact of hyperhidrosis on quality of life is comparable to, or greater than, psoriasis or eczema. Glycopyrronium tosylate (GT; formerly DRM04) is a cholinergic receptor antagonist developed for topical application for the treatment of primary axillary hyperhidrosis. ATMOS-1 (NCT02530281) and ATMOS-2 (NCT02530294) were designed to assess the efficacy and safety of GT in patients with primary axillary hyperhidrosis.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
More News: Diets | Eczema | Health | Learning | Nutrition | Psoriasis | Universities & Medical Training